Skip to main content
NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ: NMTC · Real-Time Price · USD
0.729
+0.068 (10.26%)
At close: Nov 20, 2024, 4:00 PM
0.670
-0.059 (-8.07%)
After-hours: Nov 20, 2024, 4:18 PM EST

NMTC Revenue

NeuroOne Medical Technologies had revenue of $825.78K in the quarter ending June 30, 2024, with 31.10% growth. This brings the company's revenue in the last twelve months to $3.92M, down -16.13% year-over-year. In the fiscal year ending September 30, 2023, NeuroOne Medical Technologies had annual revenue of $3.41M with 60.73% growth.

Revenue (ttm)
$3.92M
Revenue Growth
-16.13%
P/S Ratio
4.62
Revenue / Employee
$245,156
Employees
16
Market Cap
22.46M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 20233.41M1.29M60.73%
Sep 30, 20222.12M1.88M772.60%
Sep 30, 2021242.96K-1.68M-87.39%
Sep 30, 20201.93M--
Sep 30, 2019---
Sep 30, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Concord Medical Services Holdings 64.91M
Bionano Genomics 33.33M
Bolt Biotherapeutics 9.78M
NeurAxis 2.46M
Apollomics 2.10M
CytoMed Therapeutics 330.25K
Revenue Rankings

NMTC News

More News